FLOTEK INDUSTRIES INC/CN000092805412/312025Q3FALSEP7YP5Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesftk:segmentxbrli:pureftk:fleet00009280542025-01-012025-09-3000009280542025-11-0300009280542025-09-3000009280542024-12-310000928054us-gaap:NonrelatedPartyMember2025-09-300000928054us-gaap:NonrelatedPartyMember2024-12-310000928054us-gaap:RelatedPartyMember2025-09-300000928054us-gaap:RelatedPartyMember2024-12-310000928054us-gaap:NonrelatedPartyMember2025-07-012025-09-300000928054us-gaap:NonrelatedPartyMember2024-07-012024-09-300000928054us-gaap:NonrelatedPartyMember2025-01-012025-09-300000928054us-gaap:NonrelatedPartyMember2024-01-012024-09-300000928054us-gaap:RelatedPartyMember2025-07-012025-09-300000928054us-gaap:RelatedPartyMember2024-07-012024-09-300000928054us-gaap:RelatedPartyMember2025-01-012025-09-300000928054us-gaap:RelatedPartyMember2024-01-012024-09-3000009280542025-07-012025-09-3000009280542024-07-012024-09-3000009280542024-01-012024-09-3000009280542023-12-3100009280542024-09-300000928054us-gaap:CommonStockMember2025-06-300000928054us-gaap:TreasuryStockCommonMember2025-06-300000928054us-gaap:AdditionalPaidInCapitalMember2025-06-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000928054us-gaap:RetainedEarningsMember2025-06-3000009280542025-06-300000928054us-gaap:RetainedEarningsMember2025-07-012025-09-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300000928054us-gaap:CommonStockMember2025-07-012025-09-300000928054us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300000928054us-gaap:TreasuryStockCommonMember2025-07-012025-09-300000928054us-gaap:CommonStockMember2025-09-300000928054us-gaap:TreasuryStockCommonMember2025-09-300000928054us-gaap:AdditionalPaidInCapitalMember2025-09-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300000928054us-gaap:RetainedEarningsMember2025-09-300000928054us-gaap:CommonStockMember2024-06-300000928054us-gaap:TreasuryStockCommonMember2024-06-300000928054us-gaap:AdditionalPaidInCapitalMember2024-06-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000928054us-gaap:RetainedEarningsMember2024-06-3000009280542024-06-300000928054us-gaap:RetainedEarningsMember2024-07-012024-09-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000928054us-gaap:TreasuryStockCommonMember2024-07-012024-09-300000928054us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300000928054us-gaap:CommonStockMember2024-09-300000928054us-gaap:TreasuryStockCommonMember2024-09-300000928054us-gaap:AdditionalPaidInCapitalMember2024-09-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300000928054us-gaap:RetainedEarningsMember2024-09-300000928054us-gaap:CommonStockMember2024-12-310000928054us-gaap:TreasuryStockCommonMember2024-12-310000928054us-gaap:AdditionalPaidInCapitalMember2024-12-310000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000928054us-gaap:RetainedEarningsMember2024-12-310000928054us-gaap:RetainedEarningsMember2025-01-012025-09-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300000928054us-gaap:CommonStockMember2025-01-012025-09-300000928054us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300000928054us-gaap:TreasuryStockCommonMember2025-01-012025-09-300000928054us-gaap:CommonStockMember2023-12-310000928054us-gaap:TreasuryStockCommonMember2023-12-310000928054us-gaap:AdditionalPaidInCapitalMember2023-12-310000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000928054us-gaap:RetainedEarningsMember2023-12-310000928054us-gaap:RetainedEarningsMember2024-01-012024-09-300000928054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000928054us-gaap:TreasuryStockCommonMember2024-01-012024-09-300000928054us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300000928054us-gaap:CommonStockMember2024-01-012024-09-300000928054us-gaap:CommonStockMember2024-07-012024-09-3000009280542024-01-012024-12-310000928054ftk:AcquiredAssetsMember2025-04-282025-04-280000928054ftk:AcquiredAssetsMember2025-07-090000928054ftk:April2025WarrantsMemberftk:AcquiredAssetsMember2025-04-280000928054ftk:April2025WarrantsMember2025-04-280000928054ftk:April2025WarrantsMember2025-04-282025-04-280000928054us-gaap:SecuredDebtMemberus-gaap:ConvertibleDebtMember2025-04-282025-04-280000928054us-gaap:SecuredDebtMemberus-gaap:ConvertibleDebtMember2025-04-280000928054us-gaap:SecuredDebtMemberus-gaap:ConvertibleDebtMember2025-09-300000928054us-gaap:SecuredDebtMemberus-gaap:ConvertibleDebtMember2025-07-012025-09-300000928054us-gaap:SecuredDebtMemberus-gaap:ConvertibleDebtMember2025-01-012025-09-300000928054ftk:ContractServiceFeeMember2024-01-012024-12-310000928054ftk:AcquiredAssetsMemberftk:ContractServiceFeeMember2024-01-012024-12-310000928054ftk:AcquiredAssetsMember2025-01-012025-09-300000928054us-gaap:ProductMember2025-07-012025-09-300000928054us-gaap:ProductMember2024-07-012024-09-300000928054us-gaap:ProductMember2025-01-012025-09-300000928054us-gaap:ProductMember2024-01-012024-09-300000928054us-gaap:ServiceMember2025-07-012025-09-300000928054us-gaap:ServiceMember2024-07-012024-09-300000928054us-gaap:ServiceMember2025-01-012025-09-300000928054us-gaap:ServiceMember2024-01-012024-09-300000928054ftk:RentalMember2025-07-012025-09-300000928054ftk:RentalMember2024-07-012024-09-300000928054ftk:RentalMember2025-01-012025-09-300000928054ftk:RentalMember2024-01-012024-09-300000928054us-gaap:ProductAndServiceOtherMember2025-07-012025-09-300000928054us-gaap:ProductAndServiceOtherMember2024-07-012024-09-300000928054us-gaap:ProductAndServiceOtherMember2025-01-012025-09-300000928054us-gaap:ProductAndServiceOtherMember2024-01-012024-09-300000928054ftk:ProFracAgreementMember2022-02-020000928054ftk:ProFracAgreementMember2022-05-170000928054ftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054ftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054ftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054ftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054ftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054ftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054ftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054ftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:LandMember2025-09-300000928054us-gaap:LandMember2024-12-310000928054us-gaap:LandImprovementsMember2025-09-300000928054us-gaap:LandImprovementsMember2024-12-310000928054us-gaap:BuildingAndBuildingImprovementsMember2025-09-300000928054us-gaap:BuildingAndBuildingImprovementsMember2024-12-310000928054us-gaap:MachineryAndEquipmentMember2025-09-300000928054us-gaap:MachineryAndEquipmentMember2024-12-310000928054us-gaap:EquipmentMember2025-09-300000928054us-gaap:EquipmentMember2024-12-310000928054us-gaap:FurnitureAndFixturesMember2025-09-300000928054us-gaap:FurnitureAndFixturesMember2024-12-310000928054us-gaap:TransportationEquipmentMember2025-09-300000928054us-gaap:TransportationEquipmentMember2024-12-310000928054ftk:ComputerEquipmentAndSoftwareMember2025-09-300000928054ftk:ComputerEquipmentAndSoftwareMember2024-12-310000928054ftk:AcquiredAssetsMember2025-09-300000928054ftk:OfficeAndLabSpaceInHoustonTexasMember2025-09-300000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2023-08-012023-08-310000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2023-08-310000928054ftk:AssetBasedLoanMembersrt:MaximumMemberus-gaap:LineOfCreditMember2023-08-310000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2025-09-300000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2024-12-310000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2025-07-012025-09-300000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2024-07-012024-09-300000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2025-01-012025-09-300000928054ftk:AssetBasedLoanMemberus-gaap:LineOfCreditMember2024-01-012024-09-300000928054ftk:AssetBasedLoanMemberftk:PeriodOneMemberus-gaap:LineOfCreditMember2023-08-012023-08-310000928054ftk:AssetBasedLoanMemberftk:PeriodTwoMemberus-gaap:LineOfCreditMember2023-08-012023-08-310000928054ftk:PWRTEKNoteMemberus-gaap:SecuredDebtMember2025-09-300000928054ftk:PaycheckProtectionProgramCARESActMemberus-gaap:UnsecuredDebtMember2020-04-012020-04-300000928054ftk:PaycheckProtectionProgramCARESActMemberus-gaap:UnsecuredDebtMember2023-01-052023-01-050000928054ftk:PaycheckProtectionProgramCARESActMemberus-gaap:UnsecuredDebtMember2023-01-040000928054ftk:PaycheckProtectionProgramCARESActMemberus-gaap:UnsecuredDebtMember2023-01-050000928054us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-09-300000928054us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-09-300000928054us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-09-300000928054us-gaap:FairValueMeasurementsRecurringMember2025-09-300000928054us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-12-310000928054us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-12-310000928054us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-12-310000928054us-gaap:FairValueMeasurementsRecurringMember2024-12-310000928054us-gaap:MeasurementInputRiskFreeInterestRateMember2024-12-310000928054us-gaap:MeasurementInputPriceVolatilityMember2024-12-310000928054us-gaap:MeasurementInputMaturityMember2024-12-310000928054us-gaap:MeasurementInputSharePriceMember2024-12-310000928054us-gaap:MeasurementInputDiscountRateMember2024-12-310000928054us-gaap:StateAndLocalJurisdictionMember2025-09-300000928054ftk:AssetAcquisitionMember2025-07-012025-09-300000928054ftk:AssetAcquisitionMember2025-01-012025-09-300000928054us-gaap:StateAndLocalJurisdictionMember2025-07-012025-09-300000928054ftk:June2022WarrantsMembersrt:AffiliatedEntityMemberftk:ProFracHoldingsLLCMember2022-06-212022-06-210000928054ftk:June2022WarrantsMembersrt:AffiliatedEntityMemberftk:ProFracHoldingsLLCMember2022-06-210000928054us-gaap:RelatedPartyMember2024-09-300000928054us-gaap:RelatedPartyMemberftk:PIPETransactionMemberus-gaap:ConvertibleDebtMember2022-02-020000928054us-gaap:RelatedPartyMemberftk:AmendedProFracAgreementMemberus-gaap:ConvertibleDebtMember2022-05-170000928054us-gaap:RelatedPartyMemberftk:AmendedProFracAgreementMemberus-gaap:ConvertibleDebtMember2022-05-172022-05-170000928054ftk:ContractShortfallFeesMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054ftk:ContractShortfallFeesMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054ftk:ContractShortfallFeesMemberus-gaap:RelatedPartyMember2024-07-012024-09-300000928054ftk:ContractShortfallFeesMemberus-gaap:RelatedPartyMember2024-01-012024-09-300000928054ftk:ProFracGDMLLCMember2025-04-282025-04-280000928054ftk:ProFracHoldingsLLCMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054ftk:ProFracHoldingsLLCMemberus-gaap:RelatedPartyMember2024-07-012024-09-300000928054ftk:ProFracHoldingsLLCMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054ftk:ProFracHoldingsLLCMemberus-gaap:RelatedPartyMember2024-01-012024-09-300000928054ftk:ProFracHoldingsLLCMember2025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMember2025-07-012025-09-300000928054us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2025-07-012025-09-300000928054us-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:NonrelatedPartyMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054us-gaap:ProductMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054us-gaap:ServiceMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:RentalMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:RentalMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMemberftk:RentalMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054ftk:RentalMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:ChemistryTechnologiesSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:DataAnalyticsSegmentMember2025-07-012025-09-300000928054us-gaap:CorporateNonSegmentMember2025-07-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMember2024-07-012024-09-300000928054us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2024-07-012024-09-300000928054us-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:NonrelatedPartyMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:RelatedPartyMember2024-07-012024-09-300000928054us-gaap:ProductMemberus-gaap:RelatedPartyMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMember2024-07-012024-09-300000928054us-gaap:ServiceMemberus-gaap:RelatedPartyMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:RelatedPartyMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberftk:ChemistryTechnologiesSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberftk:DataAnalyticsSegmentMember2024-07-012024-09-300000928054us-gaap:CorporateNonSegmentMember2024-07-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMember2025-01-012025-09-300000928054us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2025-01-012025-09-300000928054us-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:NonrelatedPartyMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054us-gaap:ProductMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054us-gaap:ServiceMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:RentalMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:RentalMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMemberftk:RentalMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054ftk:RentalMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:ChemistryTechnologiesSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberftk:DataAnalyticsSegmentMember2025-01-012025-09-300000928054us-gaap:CorporateNonSegmentMember2025-01-012025-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:NonrelatedPartyMember2024-01-012024-09-300000928054us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2024-01-012024-09-300000928054us-gaap:ServiceMemberus-gaap:NonrelatedPartyMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:NonrelatedPartyMemberftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:NonrelatedPartyMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ProductMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ProductMemberus-gaap:RelatedPartyMember2024-01-012024-09-300000928054us-gaap:ProductMemberus-gaap:RelatedPartyMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:ServiceMemberus-gaap:RelatedPartyMember2024-01-012024-09-300000928054us-gaap:ServiceMemberus-gaap:RelatedPartyMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberus-gaap:RelatedPartyMemberftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:CorporateNonSegmentMemberus-gaap:RelatedPartyMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberftk:ChemistryTechnologiesSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberftk:DataAnalyticsSegmentMember2024-01-012024-09-300000928054us-gaap:CorporateNonSegmentMember2024-01-012024-09-300000928054us-gaap:OperatingSegmentsMemberftk:ChemistryTechnologiesSegmentMember2025-09-300000928054us-gaap:OperatingSegmentsMemberftk:ChemistryTechnologiesSegmentMember2024-12-310000928054us-gaap:OperatingSegmentsMemberftk:DataAnalyticsSegmentMember2025-09-300000928054us-gaap:OperatingSegmentsMemberftk:DataAnalyticsSegmentMember2024-12-310000928054us-gaap:CorporateNonSegmentMember2025-09-300000928054us-gaap:CorporateNonSegmentMember2024-12-310000928054country:US2025-07-012025-09-300000928054country:US2024-07-012024-09-300000928054country:US2025-01-012025-09-300000928054country:US2024-01-012024-09-300000928054country:AE2025-07-012025-09-300000928054country:AE2024-07-012024-09-300000928054country:AE2025-01-012025-09-300000928054country:AE2024-01-012024-09-300000928054us-gaap:NonUsMember2025-07-012025-09-300000928054us-gaap:NonUsMember2024-07-012024-09-300000928054us-gaap:NonUsMember2025-01-012025-09-300000928054us-gaap:NonUsMember2024-01-012024-09-300000928054us-gaap:RelatedPartyMemberftk:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-07-012025-09-300000928054us-gaap:RelatedPartyMemberftk:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300000928054us-gaap:RelatedPartyMemberftk:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-09-300000928054us-gaap:RelatedPartyMemberftk:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300000928054ftk:CustomerAMember2025-09-300000928054ftk:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-09-300000928054ftk:CustomerBMember2025-09-300000928054ftk:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-09-300000928054ftk:CustomerCMember2025-09-300000928054ftk:CustomerCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-09-300000928054ftk:CustomerAMember2024-12-310000928054ftk:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310000928054ftk:CustomerBMember2024-12-310000928054ftk:CustomerCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310000928054ftk:CustomerCMember2024-12-310000928054ftk:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310000928054ftk:SupplierAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2025-07-012025-09-300000928054ftk:SupplierBMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2025-07-012025-09-300000928054ftk:SupplierCMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2025-07-012025-09-300000928054ftk:SupplierDMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2025-07-012025-09-300000928054ftk:SupplierDMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2024-07-012024-09-300000928054ftk:SupplierAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2024-07-012024-09-300000928054ftk:SupplierCMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2024-07-012024-09-300000928054ftk:SupplierEMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2024-07-012024-09-300000928054ftk:SupplierAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2025-01-012025-09-300000928054ftk:SupplierDMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2025-01-012025-09-300000928054ftk:SupplierAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2024-01-012024-09-300000928054ftk:SupplierDMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2024-01-012024-09-300000928054ftk:SupplierCMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsSegmentMember2024-01-012024-09-30

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 10-Q
☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
			For the quarterly period ended September 30, 2025
or
☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
			For the transition period from                      to
			Commission File Number 1-13270

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒

Smaller reporting company ☒ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

At November 3, 2025, there were 30,057,823 outstanding shares of the registrant’s common stock, $0.0001 par value.

 

 

This Quarterly Report on Form 10-Q, and in particular, Part I, Item 2 — “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains “forward-looking statements” within the meaning of the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are not historical facts, but instead represent the current assumptions and beliefs regarding future events of Flotek, many of which, by their nature, are inherently uncertain and outside the Company’s control. Such statements include, but are not limited to, estimates, projections, and statements related to the Company’s business plan or performance under the ProFrac Agreement (defined below) or Lease Agreement (defined below), objectives, expected operating results, and assumptions upon which those statements are based. The forward-looking statements contained in this Quarterly Report are based on information available as of the date of this Quarterly Report.

The forward-looking statements relate to future industry trends and economic conditions, forecast performance or results of current and future initiatives and the outcome of contingencies and other uncertainties that may have a significant impact on the Company’s business, future operating results and liquidity. These forward-looking statements generally are identified by words including but not limited to, “anticipate,” “believe,” “estimate,” “commit,” “budget,” “aim,” “potential,” “schedule,” “continue,” “intend,” “expect,” “plan,” “forecast,” “target,” “think,” “likely,” “project” and similar expressions, or future-tense or conditional constructions such as “will,” “may,” “should,” “could” and “would,” or the negative thereof or other variations thereon or comparable terminology. The Company cautions that these statements are merely predictions and are not to be considered guarantees of future performance. Forward-looking statements may also include statements regarding the anticipated performance under long-term supply or lease agreements or amendments thereto and the potential value thereof or potential revenue or liquidated damages thereunder. Forward-looking statements are based upon current expectations and assumptions that are subject to risks and uncertainties that can cause actual results to differ materially from those projected, anticipated or implied.

A detailed discussion of potential risks and uncertainties that could cause actual results and events to differ materially from forward-looking statements include, but are not limited to, those discussed in Part I, Item 1A — “Risk Factors” of the Annual Report on Form 10-K for the year ended December 31, 2024 (“Annual Report” or “2024 Annual Report”) filed with the Securities and Exchange Commission (“SEC”) on March 12, 2025 and Part II, Item 1A — “Risk Factors” in this Quarterly Report, and periodically in subsequent reports filed with the SEC. The Company has no obligation, and we disclaim any obligation, to publicly update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law.

In certain places in this Quarterly Report on Form 10-Q, we may refer to statements provided by third parties that purport to describe trends or developments in supply chain or energy exploration and production activity and we specifically disclaim any responsibility for the accuracy and completeness of such information and have undertaken no steps to update or independently verify such information.

The following information contained in this Quarterly Report on Form 10-Q should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included in Part 1, Item 1 of this Quarterly Report on Form 10-Q and related disclosures and our 2024 Annual Report.

    

The Company’s Chemistry Technologies (“CT”) segment designs, develops, manufactures, packages, distributes and markets optimized chemistry solutions that we believe help customers improve their return on invested capital, lower operational costs and realize tangible environmental benefits aimed at enhancing the profitability of hydrocarbon producers.

The DA segment generates revenues through a combination of short and long-term equipment rentals (service revenue) and capital sales (product revenue). Customers of the DA segment span across the oil and gas industry, including oil and gas supermajors, some of the largest midstream oil and gas companies, large gas processing plants, independent exploration and production companies and oil field service companies that provide hydraulic fracturing services. We believe customers using our technology may obtain significant benefits, including additional profits, by enhancing operations in crude/condensates stabilization, enhancing blending operations, reducing time impacting transmix operations and increasing efficiencies and optimization of gas plants. The DA segment has expanded its presence in providing mobile power generation solutions through the acquisition of the assets described in Note 3, “Asset Acquisition.” These assets facilitate the use of significantly lower-cost field gas, as a replacement to diesel, to generate power, lower emissions and protect equipment through the continuous measurement of gas quality.

The Company’s two operating segments, CT and DA, are supported by its Research & Innovation (“R&I”) advanced laboratory capabilities. For further discussion of our operations and segments, see Note 18, “Business Segment, Geographic and Major Customer Information.”

As used herein, “Flotek,” the “Company,” “we,” “our” and “us” refers to Flotek Industries, Inc. and/or the Company’s wholly-owned subsidiaries. The use of these terms is not intended to connote any particular corporate status or relationship.

Please refer to Note 2, “Summary of Significant Accounting Policies” to the consolidated financial statements from the 2024 Annual Report for the discussion of significant accounting policies.

Changes in the allowance for credit losses are as follows (in thousands):

As of September 30, 2025 and December 31, 2024, the Company had not recorded an allowance for credit losses for the related party accounts receivable from ProFrac Services, LLC (“ProFrac Services”) (see Note 17, “Related Party Transactions”).

The Company accounts for leasing arrangements in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 842, “Leases” (“ASC 842”). On April 28, 2025, the Company entered into an equipment lease, the Lease Agreement (as defined below), with a related party customer under an operating lease arrangement (see Note 3, “Asset Acquisition”). At contract inception, an evaluation was performed to determine if the lease arrangement conveys the right to control the use of an identified asset. To the extent such rights of control were conveyed, a further assessment is made as to the applicable lease classification. In determining whether a transaction should be classified as a sales-type or operating lease, the Company considers the following criteria at lease commencement: (1) whether title of the asset transfers automatically or for a nominal fee by the end of the lease term, (2) whether the present value of the minimum lease payments equals or exceeds substantially all of the fair value of the leased asset, (3) whether the lease term is for the major part of the remaining economic life of the leased asset, (4) whether the lease grants the lessee an option to purchase the leased asset that the lessee is reasonably certain to exercise, and (5) whether the underlying asset is of such a specialized nature that it is expected to have no alternative use to the Company at the end of the lease term. If any of these criteria are met, the lease is classified as a sales-type lease. Based on the Company’s assessment, and in accordance with ASC 842, the Lease Agreement was classified as an operating lease.

For the three and nine months ended September 30, 2025 and 2024, the Company did not have any sales-type leases. For operating leases, rental income is recognized on a straight-line basis over the lease term as lease revenue. The cost of customer-leased equipment is recorded within Property and equipment, net in the balance sheet and depreciated over the equipment’s estimated useful life. Depreciation expense associated with the leased equipment under operating lease arrangements is reflected in Depreciation in the statements of operations.

Changes to U.S. GAAP are established by the FASB. We evaluate the applicability and impact of all authoritative guidance issued by the FASB. Guidance not listed below was assessed and determined to be either not applicable, clarifications of items listed below, have no material effect on the Company’s financial statements or already adopted by the Company.

In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 provide for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for the Company prospectively to all annual periods beginning for the annual period ending December 31, 2025. Early adoption is permitted. This is expected to result in expanded tax disclosures in the annual financial statements for the year ended December 31, 2025.

The FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures” (“ASU 2024-03”), which enhances the disclosures required for certain expense captions in the Company's annual and interim consolidated financial statements. ASU 2024-03 is effective prospectively or retrospectively for fiscal years beginning after December 15, 2026 and for interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this standard on its disclosures.

The Company entered into a series of transactions in connection with an Asset Purchase Agreement, dated as of April 28, 2025 (the “Purchase Agreement”), with ProFrac GDM, LLC (“ProFrac GDM”), an indirect subsidiary of ProFrac Holding Corp. (“ProFrac”), and various subsidiaries of ProFrac, pursuant to which, among other things, the Company acquired certain mobile power generation assets, comprised of twenty-two operating units and eight units under construction, certain inventory and related intellectual property (the “Acquired Assets”). Concurrently, the Leased Equipment (as defined below) was leased back to ProFrac GDM pursuant to an Agreement for Equipment Rental, dated as of April 28, 2025, by and between PWRtek, LLC (“PWRtek”), a wholly-owned subsidiary of the Company, and ProFrac GDM (the “Lease Agreement”) (collectively, the “PWRtek Transactions”). In accordance with FASB ASC 805, “Business Combinations,” the acquisition of the Acquired Assets is classified as an asset acquisition between entities under common control.

Pursuant to the terms of the Lease Agreement, ProFrac GDM agreed to lease from PWRtek, for a period of six years, twenty-two operating mobile power generation assets, comprised of fourteen digitally enhanced mobile natural gas power generation filtration units and eight gas distribution units and eight additional units, comprised of seven gas distribution units and one mobile natural gas power generation filtration unit, that were under construction (collectively, the “Leased Equipment”) as of April 28, 2025. The Lease Agreement provides for fixed rental rates for the Leased Equipment during the first five years of the Lease Agreement and then prevailing market rates during the sixth year.

The Lease Agreement does not include a purchase option for the purchase of the Leased Equipment at the end of the Lease Agreement term. The Company began recognizing lease revenue associated with the twenty-two operating mobile power generation assets on April 28, 2025, the effective date of the Lease Agreement. With respect to the Leased Equipment under construction, the Company began recognizing lease revenue on the respective dates each of the eight units were placed in-service. As of September 30, 2025, all of the eight units under construction as of April 28, 2025 had been completed and placed in-service.

Total consideration paid by the Company in connection with the PWRtek Transactions was $107.5 million, which consisted of the following: (1) an offset of $17.6 million against the Company’s accrued 2024 Contract Shortfall Fee (see Note 17, “Related Party Transactions”), which was the consideration for the acquisition of the Acquired Assets, (2) a warrant (the “April 2025 Warrant”) to purchase 6,000,000 shares of the Company’s common stock, (3) a secured promissory note, issued by PWRtek in the initial principal amount of $40 million (the “PWRtek Note”), and (4) offsets against potential future period Contract Shortfall Fee amounts that may become due under the ProFrac Agreement (see Note 17, “Related Party Transactions”). The estimated fair value of the Leased Equipment was deemed to be in excess of the total consideration of $107.5 million.

The April 2025 Warrant has a seven-year term and can be exercised on a cashless basis for nominal consideration at any time following the date on which the Company’s stockholders have approved the issuance of the shares of the Company’s common stock underlying the April 2025 Warrant. On July 9, 2025, the Company held a special stockholders meeting where the Company’s stockholders approved the issuance of the 6,000,000 shares of the Company’s common stock underlying the April 2025 Warrant. The fair value of the April 2025 Warrant was $42.7 million. The Company recorded the fair value of the April 2025 Warrant as additional paid in capital within stockholders’ equity, net of $0.7 million of issuance costs, as the April 2025 Warrant is classified as equity. As of September 30, 2025, the April 2025 Warrant had not been exercised.

The PWRtek Note provides for a five-year term and is subject to a 10% annual interest rate, payable quarterly in cash or in-kind (i.e., added to the principal balance quarterly) at PWRtek’s option. The principal becomes due at the end of the five-year term on April 28, 2030. PWRtek’s obligations under the PWRtek Note are secured by a first priority lien on the Acquired Assets, including the Leased Equipment, as well as certain other after-acquired property of PWRtek. While the PWRtek Note includes certain prepayment restrictions, Flotek and ProFrac GDM can each elect to apply up to fifty percent cumulatively of any future Contract Shortfall Fee (see Note 17, “Related Party Transactions”) that becomes due and payable under the ProFrac Agreement to prepay principal and interest due under the PWRtek Note without penalty. The obligations under the PWRtek Note have been guaranteed by the Company. The Company recorded $0.5 million as deferred financing costs on April 28, 2025. As of September 30, 2025, there was $39.6 million outstanding, net of unamortized deferred financing costs of $0.4 million under the PWRtek Note. See Note 10 - “Debt” for additional information. For the three and nine months ended September 30, 2025, interest expense related to the PWRtek Note was $1.0 million and $1.7 million, respectively. As of September 30, 2025, interest payable related to the PWRtek Note was $1.0 million.

Contract Shortfall Fees for the measurement period of January 1, 2024 through December 31, 2024 totaled approximately $32.6 million (the “2024 Contract Shortfall Fees”) and was included in accounts receivable, related party as of December 31, 2024. The Company collected $15.0 million of the 2024 Contract Shortfall Fees in cash in March 2025. The remaining 2024 Contract Shortfall Fees of $17.6 million were offset as consideration for the Acquired Assets as described above.

Due to ProFrac controlling more than 50% of the Company’s outstanding shares (see Note 17, “Related Party Transaction”), the acquisition of the Acquired Assets qualified as a transfer of assets between entities under common control. As such, the Acquired Assets were recorded at ProFrac’s historical book value of approximately $14.9 million. The total consideration paid by the Company in connection with the PWRtek Transactions in excess of ProFrac’s historical book value of the Acquired Assets of $92.6 million was recorded as a reduction to additional paid in capital for the PWRtek Transactions within stockholders’ equity during the nine months ended September 30, 2025. Financial results from the Lease Agreement and operation of the Acquired Assets are reported within the Company’s DA segment. See Note 8, “Leases” for additional information.

The following table summarizes the consideration transferred and the historical book value of identified Acquired Assets at the date of the PWRtek Transactions (in thousands):

The Company differentiates revenue based on whether the source of revenue is attributable to product sales, service revenue or rental income. Product, service and rental revenues include sales to related parties as described in Note 17, “Related Party Transactions.”

Total revenue disaggregated by revenue source is as follows (in thousands):

The Company differentiates cost of sales based on whether the cost is attributable to tangible goods sold, cost of services sold or other costs that cannot be directly attributed to either tangible goods or services.

Total cost of sales disaggregated is as follows (in thousands):

Other cost of sales represents costs directly associated with the generation of revenue that cannot be attributed directly to tangible goods sold or services. Other cost of sales for the three and nine months ended September 30, 2025 includes $0.6 million and $0.8 million, respectively, related to the Lease Agreement. Examples of other costs of sales are certain personnel costs and equipment rental and insurance costs.

Cost of sales, disaggregated between external customers and related party, is as follows (in thousands):

Contract assets are as follows (in thousands):

In connection with entering into the Initial ProFrac Agreement (defined below) and Amended ProFrac Agreement (defined below) on February 2, 2022 and May 17, 2022, respectively, as discussed in Note 17, “Related Party Transactions,” the Company recognized contract assets of $10.0 million and $69.5 million, respectively, and associated fees of $3.6 million. As of September 30, 2025 and December 31, 2024, $56.7 million and $63.1 million, respectively, of the contract assets were classified as long term based upon our estimate of the forecasted revenues from the ProFrac Agreement that will not be realized within the next twelve months of the ProFrac Agreement. The Company’s estimate of the timing of the future contract revenues is evaluated on a quarterly basis.

During the three months ended September 30, 2025 and 2024, the Company recognized $1.3 million and $1.6 million, respectively, of contract assets amortization that is recorded as a reduction of the transaction price included in related party revenue in the consolidated statement of operations. During the nine months ended September 30, 2025 and 2024, the Company recognized $4.2 million and $4.3 million, respectively, of contract assets amortization that is recorded as a reduction of the transaction price included in related party revenue in the consolidated statement of operations. The table below reflects our estimated amortization per year (in thousands) based on the Company’s forecasted revenues from the ProFrac Agreement as of September 30, 2025.

Inventories are as follows (in thousands):

			September 30, 2025						December 31, 2024
Raw materials			$	4,830					$	4,945
Finished goods			12,858						13,581
Inventories			17,688						18,526
Less reserve for excess and obsolete inventory			(4,456)						(5,223)
Inventories, net			$	13,232					$	13,303

During the three months ended September 30, 2025 and 2024, additional reserves recorded were $28 thousand and $0.2 million, respectively, for the CT segment. For the three months ended September 30, 2025, additional reserves of $28 thousand were recorded for the DA segment with no additional reserves recorded for the three months ended September 30, 2024.

During the nine months ended September 30, 2025 and 2024, additional reserves recorded were $0.3 million and $0.6 million, respectively, for the CT segment and $45 thousand and $13 thousand, respectively, for the DA segment.

Property and equipment are as follows (in thousands):

			September 30, 2025						December 31, 2024
Land			$	886					$	886
Land improvements			520						520
Buildings and leasehold improvements			6,643						5,722
Machinery and equipment			8,975						8,524
Leased equipment			14,252						—
Furniture and fixtures			520						520
Transportation equipment			805						790
Computer equipment and software			1,698						1,531
Property and equipment			34,299						18,493
Less accumulated depreciation			(13,477)						(12,315)
Property and equipment, net			$	20,822					$	6,178

Leased equipment (See Note 3, “Asset Acquisition”) has an estimated useful life of ten years.

Depreciation expense totaled $0.6 million and $0.2 million for the three months ended September 30, 2025 and 2024, respectively. Depreciation expense totaled $1.2 million and $0.7 million for the nine months ended September 30, 2025 and 2024, respectively.

The components of lease expense and supplemental cash flow information are as follows (in thousands):

Maturities of lease liabilities as of September 30, 2025 are as follows (in thousands):

Supplemental balance sheet information related to leases is as follows (in thousands):